Web-based telemedicine system is useful for monitoring glucose control in pregnant women with diabetes.
Source: Carral, F., et al. (2015). - Pubmed ID: 25629547
Setting: Spain, University hospital
CT –pro
Follow up: NA
Sample size:
Total: 104 (93)
IG: 40 (38)
CG: 64 (55)
Inclusion criteria:
- Age over 18 years
- Diabetes before or during pregnancy
Website (‘diabetic’)
- Data transfer
- Monitoring
- Messaging
Email or phone
- Feedback on data
Intervention: Glucose control was evaluated every 2 weeks on a Web-based telemedicine system called ‘‘DiabeTIC’’ with feedback by email or phone message. Furthermore in clinic evaluation at the diabetes unit every 6–8 weeks. All patients were reevaluated in a face-to-face visit between 6 to 12 weeks after delivery.
Duration: NA
Add on: –
Control group: Glucose was evaluated every 2 or 3 weeks until delivery at a diabetes unit.
Clinical effect:
- HbA1c →
- Insulin therapy ↓
- Cesarean delivery →
Patient safety: NA
Patient experiences: NA
Staff experiences: NA
Investment:
Material
- Bloodglucose monitor
Staff resources
- Development of website
Running:
Staff resources
- Monitoring patients
- Messaging patients
Organization: NA
Health care utilization:
- Diabetes unit visits ↓
- Nurse educator visits ↓
- GP visits ↓